In vitro activity of sertaconazole against Malassezia furfur and pachydermatis in different culture media

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 20, Issue 6, 1998, Pages 451-455

  Palacin, C ^a   Tarrago C ^a   Ortiz, J A ^a  

^a Centro de Investigaciones Farmaceuticos Grupo Ferrer   (Spain)

Author keywords

In vitro activity; Malassezia; Sertaconazole

Indexed keywords

SERTACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CULTURE MEDIUM; DRUG EFFICACY; DRUG SCREENING; MALASSEZIA FURFUR; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; STRAIN DIFFERENCE;

ANTIFUNGAL AGENTS; CULTURE MEDIA; IMIDAZOLES; MALASSEZIA; MICROBIAL SENSITIVITY TESTS; THIOPHENES;

EID: 0031693125     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1998.20.6.485707     Document Type: Article

References (17)

1. Ingham, E., Cunningham, A.C. Malassezia furfur. J Med Vet Mycol 1993, 31: 265-88.
2. Leeming, J.P., Notman, F.H., Holland, K.T. The distribution and ecology of Malassezia furfur and cutaneous bacteria on human skin. J Appl Bacterial 1989, 67: 47-52.
3. Faegenimn, J., Maibach, H.I. The Pityrosporum yeasts. Their role as pathogens. Int J Dermatol 1984, 23: 463-65.
4. Borton, L.K., Chwartz, R.A. Pityrosporum folliculitis. A common acneiform condition of middle age. Ariz Med 1981, 38: 598-601.
5. Parunovic, A., Halde, C. Pityrosparum orbiculare. Its possible role in seborrhoeic blepharitis. Am J Opthalmol 1967, 63: 815-20.
6. Waersted, A., Hjorth, N. Pityrosporum orbiulare a pathogenic factor in atopic dermatitis of the face, scalp and neck? Acta Derin Venereol 1985, (Suppl. 114): 146-8.
7. Faegernian, J. Pityrosporum yeasts-what's new? Mycoses 1997, 40(Suppl 1): 29-32.
8. Pfaller, M.A., Vu, Q., Lancanter, M. et al. Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates. J Clinical Microbiol 1994, 32(7): 1625-8.
9. Leeming, J.P., Notman, F.H. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J Clin Microbiol 1987, 25: 2017.
10. Schmidt, A., Rüll-Höster, B. In vitro susceptibility of Malassezia furfur. Arzneiniittelforschung 1996, 46(NI): 442-4.
11. Torres-Rodriguez, J.M., Alayeto, J., Palacin, C., Alia, C. Evaluation de deux nouveax antimycosiques imidazoliques in vitro sur levures, dermatophytes et Scopularionsis. Bull Soc Fr Mycol Méd 1986, XV (2): 529-32.
12. Drohuet, E., Dupon, B. In vitro antifungal activity of sertaconazole. Arzneimittelforschung 1992, 42 (1), 5a: 705-10.
13. Van Gerven, F., Odds. F.C. The anti-Malassezia furfur activity in vitro and in experimental dermatitis of six imidazole antifungal agents: bifonazole, clotrimazole, flutrimazole, ketoconazole, miconazole and sertaconazole, Mycoses 1995, 38: 389-393.
14. Van Cutsern, J., Van Gerven, F., Fransen, J., Schooten, P., Janssen, P.A. The in vitro antifungal activity of ketoconazole, zinc pyrithione, and selenium sulfide against Pityrosporum and their efficacy as a shampoo in the treatment of experimental pityrosporosis in guinea pigs. J Am Acad Dermat 1990, 22(6, part 1): 993-8.
15. Schmidt, A., Rüll-Höstcr. B. In vitro suscepibility of Malassezia furfur against azole compounds. Mycoses 1996, 39: 309-12.
16. Szlachcic, A., Fillat, O., Herrero, E., Márquez, M., Torres, J., Camps, F., Ortiz, J.A. Efficacy and Safety of sertaconazole 2% gel vs ketoconazole 2% gel in the treatment of seborrheic dermatitis on the scalp. XXVI Congreso Nacional de Dermatologia y Venerologia (May. Málaga) 1997: Poster 6.
17. Nasaffe, J., Umbert, P., Horero, E. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor. Arzneim Forsch/Drug Res 1992, 42(1), 5a: 764-7.